Release Date: 2024-05-30

Depression and Transcranial Magnetic Stimulation

Ezgi Cankaya Inan (Author), Betul Uyar (Author)

Release Date: 2024-05-30

Transcranial Magnetic Stimulation (TMS) is one of the current and non-invasive neuromodulation techniques that can be used in the treatment of many mental illnesses. It works by using magnetic fields without causing seizures or loss of consciousness. It is based on the principle that the magnetic field created by a coil through which electric current [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inDepression Treatment Updates
    First Page65
    Last Page83
    DOIhttps://doi.org/10.69860/nobel.9786053359456.4
    Page Count19
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

    Transcranial Magnetic Stimulation (TMS) is one of the current and non-invasive neuromodulation techniques that can be used in the treatment of many mental illnesses. It works by using magnetic fields without causing seizures or loss of consciousness. It is based on the principle that the magnetic field created by a coil through which electric current passes creates a small, temporary electrical field in the nerve cells. In recent years, its use in the treatment of Major Depressive Disorder (MDD) has been increasing. The fact that 20-40% of MDD patients do not respond to antidepressants and psychotherapy interventions has led to the search for alternative treatment methods, such as TMS in the treatment of MDD. In this section, the history of TMS, its mechanism of action, application methods, and the place of TMS in the treatment of MDD will be discussed.

    Ezgi Cankaya Inan (Author)
    Dicle University
    https://orcid.org/0000-0002-2221-2894
    3Psychiatrist Ezgi Çankaya İnan graduated from Çukurova University Faculty of Medicine in 2018 and received the title of Doctor of Medicine. He worked as a general practitioner at Hatay Kırıkhan State Hospital between 2018-2020 as part of his compulsory service obligation. Between 2020 and 2024, she worked as a research assistant at Dicle University, Department of Mental Health and Diseases. She received the title of Specialist Doctor in 2024. She is a member of 1 organization related to her profession.

    Betul Uyar (Author)
    Associate Professor, Dicle University
    https://orcid.org/0000-0002-6428-1097
    3Associate Professor Betül Uyar graduated from Hacettepe University Faculty of Medicine in 2008. She received her psychiatry specialization from Dicle University Faculty of Medicine between 2011 and 2015. She has been a faculty member in the Department of Psychiatry, Dicle University Medical Faculty since 2019. Dr. Uyar, who has published many national and international articles, is a member of the Turkish Psychiatric Association.

    • James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1789-1858.

    • Organization WH. Depression and other common mental disorders: global health estimates. World Health Organization;2017.

    • Aydin EF. Majör depresif bozuklukta antidepresan tedavilere verilen klinik yanıt ile bilişsel işlevler arasındaki ilişki.

    • Cracco R. Evaluation of conduction in central motor pathways: techniques, pathophysiology, and clinical interpretation. Neurosurgery. 1987;20(1):199-203.

    • Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. The Lancet. 1985;325(8437):1106-1107.

    • YÖNEY TH. Transkraniyal Manyetik Stimulasyonun Psikiyatrik Uygulamaları.

    • Abarbanel JM, Lemberg T, Yaroslavski U, Grisam N, Belmaker RH. Electrophysiological responses to transcranial magnetic stimulation in depression and schizophrenia. Biological Psychiatry. 1996;40(2):148-150.

    • Horvath JC, Mathews J, Demitrack MA, Pascual-Leone A. The NeuroStar TMS device: conducting the FDA approved protocol for treatment of depression. JoVE (Journal of Visualized Experiments). 2010(45):e2345.

    • Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Group SoTC. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical neurophysiology. 2009;120(12):2008-2039.

    • Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. International Journal of Neuropsychopharmacology. 2008;11(1):131-147.

    • Bolu A, Erdem M, Oznur T. Diagnostic Use of Transcranial Magnetic Stimulation in Psychiatry/Transkranial Manyetik Stimulasyonun Psikiyatride Tanisal Amacli Kullanimi. Psikiyatride Guncel Yaklasimlar/Current Approaches to Psychiatry. 2013;5(4):378-388.

    • Sadock B. Sadock psikiyatri davranış bilimleri/klinik psikiyatri. Bozkurt A (Çeviri Ed). 2016;11:694-737.

    • Sibon I, Strafella AP, Gravel P, et al. Acute prefrontal cortex TMS in healthy volunteers: Effects on brain 11C-αMtrp trapping. Neuroimage. 2007;34(4):1658- 1664.

    • Lang UE, Hellweg R, Gallinat J, Bajbouj M. Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: no effects on brain-derived neurotrophic factor (BDNF) concentrations in serum. Journal of affective disorders. 2008;107(1-3):255-258.

    • McIntosh AM, Semple D, Tasker K, et al. Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry research. 2004;127(1-2):9-17.

    • Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. American Journal of Psychiatry. 2003;160(5):835-845.

    • Young RR, Cracco RQ. Clinical neurophysiology of conduction in central motor pathways. In. Vol 18: Wiley Online Library; 1985:606-610.

    • Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock psikiyatri davranış bilimleri. Güneş Tıp Kitabevi; 2016.

    • Geddes LA. History of magnetic stimulation of the nervous system. Journal of Clinical Neurophysiology. 1991;8(1):3-9.

    • Cohen SL, Bikson M, Badran BW, George MS. A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices. Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation. 2022;15(1):73-75.

    • Padberg F, George MS. Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Experimental neurology. 2009;219(1):2-13.

    • ÜNSALVER BÖ, Tarhan N. Majör Depresyon Tedavisinde Transkraniyal Manyetik Uyarım Tedavisi Kullanımı. Turkiye Klinikleri J Psychiatry-Special Topics. 2017;10(2):79-87.

    • Hebel T, Göllnitz A, Schoisswohl S, et al. A direct comparison of neuronavigated and non-neuronavigated intermittent theta burst stimulation in the treatment of depression. Brain Stimulation. 2021;14(2):335-343.

    • Barker AT. An introduction to the basic principles of magnetic nerve stimulation. Journal of clinical neurophysiology. 1991;8(1):26-37.

    • Lefaucheur J-P, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clinical neurophysiology. 2020;131(2):474-528.

    • Lisanby SH, Belmaker RH. Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS). Depression and anxiety. 2000;12(3):178-187.

    • Kähkönen S, Komssi S, Wilenius J, Ilmoniemi RJ. Prefrontal TMS produces smaller EEG responses than motor-cortex TMS: implications for rTMS treatment in depression. Psychopharmacology. 2005;181:16-20.

    • Rumi DO, Gattaz WF, Rigonatti SP, et al. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biological psychiatry. 2005;57(2):162-166.

    • O’Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biological psychiatry. 2007;62(11):1208-1216.

    • Bakim B, Uzun UE, Karamustafalioglu O, et al. The combination of antidepressant drug therapy and high-frequency repetitive transcranial magnetic stimulation in medication-resistant depression. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2012;22(3):244-253.

    • Cohen RB, Boggio PS, Fregni F. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depression and anxiety. 2009;26(7):682-688.

    • Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain stimulation. 2010;3(4):187-199.

    • Chen L, Hudaib AR, Hoy KE, Fitzgerald PB. Is rTMS effective for anxiety symptoms in major depressive disorder? An efficacy analysis comparing leftsided high‐frequency, right‐sided low‐frequency, and sequential bilateral rTMS protocols. Depression and anxiety. 2019;36(8):723-731.

    • Greenberg BD, McCann UD, Benjamin J, Murphy DL. Repetitive TMS as a probe in anxiety disorders: theoretical considerations and case reports. CNS spectrums. 1997;2(1):47-52.

    • Sayar GH, Ozten E, Tan O, Tarhan N. Transcranial magnetic stimulation for treating depression in elderly patients. Neuropsychiatric disease and treatment. 2013:501-504.

    • Pridmore S, Bruno R, Turnier-Shea Y, Reid P, Rybak M. Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. International Journal of Neuropsychopharmacology. 2000;3(2):129-134.

    • Dannon PN, Dolberg OT, Schreiber S, Grunhaus L. Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals—preliminary report. Biological Psychiatry. 2002;51(8):687-690.

    • Loo CK, Mitchell P, Croker V, et al. Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression. Psychological medicine. 2003;33(1):33-40.

    • Grunhaus L, Schreiber S, Dolberg OT, Polak D, Dannon PN. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biological psychiatry. 2003;53(4):324-331.

    • Martis B, Alam D, Dowd SM, et al. Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clinical Neurophysiology. 2003;114(6):1125-1132.

    • Rossini D, Lucca A, Zanardi R, Magri L, Smeraldi E. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebocontrolled trial. Psychiatry Research. 2005;137(1-2):1-10.

    • Januel D, Dumortier G, Verdon C-M, et al. A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): therapeutic and cognitive effect in medication free unipolar depression during 4 weeks. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2006;30(1):126- 130.

    • Levkovitz Y, Isserles M, Padberg F, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry. 2015;14(1):64-73.

    • Trevizol AP, Goldberger KW, Mulsant BH, et al. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment‐resistant late‐life depression. International journal of geriatric psychiatry. 2019;34(6):822-827.

    • Tastevin M, Baumstarck K, Groppi F, et al. Double cone coil rTMS efficacy for treatment-resistant depression: a prospective randomized controlled trial. Brain Stimulation. 2020;13(1):256-258.

    • Kiebs M, Hurlemann R, Mutz J. Cognitive effects of non-surgical brain stimulation for major depressive disorder: protocol for a systematic review and meta-analysis. BMJ open. 2019;9(2):e023796.

    • Dumas R, Padovani R, Richieri R, Lançon C. Repetitive transcranial magnetic stimulation in major depression: response factor. L’encephale. 2011;38(4):360-368

    onix_3.0::thothThoth ONIX 3.0
    onix_3.0::project_museProject MUSE ONIX 3.0
    onix_3.0::oapenOAPEN ONIX 3.0
    onix_3.0::jstorJSTOR ONIX 3.0
    onix_3.0::google_booksGoogle Books ONIX 3.0
    onix_3.0::overdriveOverDrive ONIX 3.0
    onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
    csv::thothThoth CSV
    json::thothThoth JSON
    kbart::oclcOCLC KBART
    bibtex::thothThoth BibTeX
    doideposit::crossrefCrossRef DOI deposit
    onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
    marc21record::thothThoth MARC 21 Record
    marc21markup::thothThoth MARC 21 Markup
    marc21xml::thothThoth MARC 21 XML

    Share This Chapter!